$87.56
+2.6%HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.
HQY โข NASDAQ
| HealthEquity, Inc. Cash Flow Statement | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||
215.2M | 96.7M | 55.7M | -26.1M | -44.3M | 8.8M | 39.7M | 73.9M | 47.4M | 26.4M | 16.6M | 10.2M | 1.2M | 11.2M | |
154.7M | 162.5M | 153.1M | 161.2M | 137.2M | 115.9M | 55.4M | 18.2M | 16M | 13.2M | 8.6M | 5.9M | 4.3M | 3.4M | |
39.7M | -12.8M | -14M | -17.2M | -23.4M | -5.1M | 3.7M | 408K | 4.3M | -2.9M | -2.2M | 1.6M | 3.6M | -4.9M | |
73.1M | 96.4M | 77.2M | 62.6M | 52.8M | 42.9M | 39.8M | 21.1M | 14.3M | 8.4M | 5.9M | 2.5M | 57K | 47K | |
1.1M | 3.6M | 4M | 3.5M | 17.2M | 6.9M | -23.2M | 1.2M | 220K | 103K | 47K | 790K | 5.7M | 129K | |
(0.0) | (26.1M) | (35.4M) | (1.5M) | (0.0) | (0.0) | (9.3M) | (587K) | (27K) | (863K) | (1.4M) | (1.5M) | (353K) | (274K) | |
-26.6M | -6.5M | -33.1M | -33.4M | 1.6M | 12.3M | -9.5M | -1.3M | -448K | 419K | -2.4M | -5.9M | 3.2M | 2M | |
457.1M | 339.9M | 242.8M | 150.7M | 141M | 181.6M | 105.9M | 113.4M | 81.7M | 45.6M | 26.5M | 15M | 18M | 11.8M | |
INVESTING ACTIVITIES | ||||||||||||||
-2M | -2.1M | -1.7M | -119.1M | -137.1M | -97M | -42.1M | -15M | -33.4M | -12.7M | -49.8M | -8.1M | -5.4M | -2.7M | |
(0.0) | (0.0) | (0.0) | (0.0) | -504.5M | (0.0) | -1.6B | (11.2M) | -2.9M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | (0.0) | (128.2M) | (0.0) | -53.8M | -728K | -483K | -379K | -40.8M | -305K | (0.0) | (0.0) | |
0.0 | 0.0 | 0.0 | 0.0 | 2.4M | 0.0 | 34.8M | 41.4M | 27.9M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
-45.2M | -503.4M | -44.4M | 0.0 | -128.2M | 0.0 | -34.8M | -11.2M | -27.9M | -9.4M | -88.2M | -6.7M | 800K | -800K | |
-47.1M | -505.5M | -46.1M | -119.1M | -639.2M | -97M | -1.7B | (25.7M) | -36.7M | -13.1M | -90.6M | -8.4M | -4.6M | -3.5M | |
FINANCING ACTIVITIES | ||||||||||||||
-287.8M | -112.1M | 6.5M | 6.7M | 466.4M | 295.3M | 458.5M | 0.0 | 0.0 | 0.0 | 23.5M | 132.6M | 597K | 0.0 | |
-100M | 171.3M | -54.4M | -8.8M | -65M | -239.1M | 1.2B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.2M | -7.6M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -50.3M | -694K | (0.0) | |
-299.3M | -121.5M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -3.4M | (0.0) | |
867K | -1.6M | 865K | -603K | -6.5M | -3.9M | -234.9M | 22.9M | 14.6M | 23.8M | 13.2M | 8.2M | 271K | 110K | |
-387M | 57.6M | -47M | -2.7M | 394.9M | 52.4M | 1.5B | 22.9M | 14.6M | 23.8M | 36.6M | 90.5M | -5.4M | -7.5M | |
CASH FLOW SUMMARY | ||||||||||||||
23M | -108M | 149.7M | 28.9M | -103.4M | 137.1M | -169.7M | 162M | 59.5M | 56.3M | -27.4M | 97.1M | 8M | 775K | |
295.9M | 404M | 254.3M | 225.4M | 328.8M | 191.7M | 361.5M | 199.5M | 140M | 83.6M | 111M | 13.9M | 5.9M | 5.1M | |
318.9M | 295.9M | 404M | 254.3M | 225.4M | 328.8M | 191.7M | 361.5M | 199.5M | 140M | 83.6M | 111M | 13.9M | 5.9M | |
455.1M | 337.8M | 196.8M | 31.5M | 3.9M | 84.7M | 63.8M | 98.4M | 48.3M | 32.9M | -23.2M | 6.9M | 12.6M | 9M |
HQY - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q2 Q2 | May 28, 2026 | April 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 28, 2026 | May 28, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | May 13, 2026 | January 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 08, 2026 | May 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 06, 2026 | April 06, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 30, 2026 | March 26, 2026 | 2026 | |
10-K 10-K 2026 FY FY | March 17, 2026 | January 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 17, 2026 | March 17, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 17, 2026 | February 17, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 |
Continue your HQY research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.